Geviti Health, a precision health platform focused on preventative care, has announced the launch of an AI-powered health intelligence system that delivers clinically validated insights into blood biomarkers at no cost.

The platform introduces what Geviti describes as a first-to-market free offering, using AI to accelerate multi-system health analysis while supporting clinical decision-making within a human-led care model. It addresses a growing gap in preventative healthcare, where cost and complexity continue to limit access to comprehensive testing and interpretation.

Geviti aggregates data from advanced diagnostics to identify patterns and surface actionable insights, enabling faster and more comprehensive analysis at scale.

Unlike traditional models that rely on static lab interpretation or generalised recommendations, Geviti combines AI-driven analysis with expert oversight to deliver individualised health blueprints alongside ongoing monitoring and guided patient support.

“AI should not replace the human element in healthcare; it should enhance it,” said Nate Graville, founder of Geviti. “We use AI as a force multiplier, allowing our team to analyse significantly more data across biomarkers, genetics, and medical history with greater precision and speed, while still delivering personalised, human-led care.”

Graville emphasised that the platform prioritises outcomes and patient-specific insights over generalised recommendations. “It’s not about generating more data. It’s about interpreting it correctly and turning it into meaningful action,” he said.